Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

In a recent study, researchers compared the efficacy of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines against infection SARS-CoV-2.

Related Keywords

United Kingdom ,Oxford Astrazeneca Chadox ,Viacheslav Lopatin Shutterstock ,Pfizer ,Social Care ,Viacheslav Lopatin ,Coronavirus Disease Covid 19 ,Efficacy ,Ars Cov 2 ,Coronavirus ,Hospital ,Immunity ,Espiratory ,Ibonucleic Acid ,Cars ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Vaccine ,